Schedule 13D ownership disclosure

Fate Therapeutics Inc

Security class unavailable · CUSIP: 31189P102

Event date: 2023-04-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-047252
Form type
SC 13D/A
Filer
FATE THERAPEUTICS INC
CIK
CIK 1434316
Filed
Apr 19, 2023
Reporting period
Apr 13, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub